搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Dichelobacter nodosus 50S ribosomal protein L30 (rpmD) CSB-YP399606DHZ
CSB-EP399606DHZ
CSB-BP399606DHZ
CSB-MP399606DHZ
CSB-EP399606DHZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dichelobacter nodosus 30S ribosomal protein S8 (rpsH) CSB-YP399607DHZ
CSB-EP399607DHZ
CSB-BP399607DHZ
CSB-MP399607DHZ
CSB-EP399607DHZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dichelobacter nodosus Ribosomal RNA large subunit methyltransferase E (rlmE) CSB-YP399608DHZ
CSB-EP399608DHZ
CSB-BP399608DHZ
CSB-MP399608DHZ
CSB-EP399608DHZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dichelobacter nodosus Ribosomal RNA small subunit methyltransferase G (rsmG) CSB-YP399609DHZ
CSB-EP399609DHZ
CSB-BP399609DHZ
CSB-MP399609DHZ
CSB-EP399609DHZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dichelobacter nodosus 50S ribosomal protein L13 (rplM) CSB-YP399610DHZ
CSB-EP399610DHZ
CSB-BP399610DHZ
CSB-MP399610DHZ
CSB-EP399610DHZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dichelobacter nodosus 30S ribosomal protein S6 (rpsF) CSB-YP399611DHZ
CSB-EP399611DHZ
CSB-BP399611DHZ
CSB-MP399611DHZ
CSB-EP399611DHZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dichelobacter nodosus Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha (accA) CSB-YP399612DHZ
CSB-EP399612DHZ
CSB-BP399612DHZ
CSB-MP399612DHZ
CSB-EP399612DHZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dichelobacter nodosus Serine--tRNA ligase (serS) CSB-YP399613DHZ
CSB-EP399613DHZ
CSB-BP399613DHZ
CSB-MP399613DHZ
CSB-EP399613DHZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dichelobacter nodosus DNA-directed RNA polymerase subunit omega (rpoZ) CSB-YP399614DHZ
CSB-EP399614DHZ
CSB-BP399614DHZ
CSB-MP399614DHZ
CSB-EP399614DHZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dichelobacter nodosus Phosphopantetheine adenylyltransferase (coaD) CSB-YP399615DHZ
CSB-EP399615DHZ
CSB-BP399615DHZ
CSB-MP399615DHZ
CSB-EP399615DHZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dichelobacter nodosus Protein translocase subunit SecA (secA), partial CSB-YP399616DHZ
CSB-EP399616DHZ
CSB-BP399616DHZ
CSB-MP399616DHZ
CSB-EP399616DHZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dichelobacter nodosus Hydroxyethylthiazole kinase (thiM) CSB-YP399617DHZ
CSB-EP399617DHZ
CSB-BP399617DHZ
CSB-MP399617DHZ
CSB-EP399617DHZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dichelobacter nodosus Ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP399618DHZ
CSB-EP399618DHZ
CSB-BP399618DHZ
CSB-MP399618DHZ
CSB-EP399618DHZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dichelobacter nodosus Octanoyltransferase (lipB) CSB-YP399619DHZ
CSB-EP399619DHZ
CSB-BP399619DHZ
CSB-MP399619DHZ
CSB-EP399619DHZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dichelobacter nodosus Deoxyuridine 5'-triphosphate nucleotidohydrolase (dut) CSB-YP399620DHZ
CSB-EP399620DHZ
CSB-BP399620DHZ
CSB-MP399620DHZ
CSB-EP399620DHZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 GMP reductase (guaC) CSB-YP399621VEY
CSB-EP399621VEY
CSB-BP399621VEY
CSB-MP399621VEY
CSB-EP399621VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Threonine--tRNA ligase (thrS), partial CSB-YP399622VEY
CSB-EP399622VEY
CSB-BP399622VEY
CSB-MP399622VEY
CSB-EP399622VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 UPF0502 protein VC0395_0676/VC395_A0574 (VC0395_0676, VC395_A0574) CSB-YP399623VEY
CSB-EP399623VEY
CSB-BP399623VEY
CSB-MP399623VEY
CSB-EP399623VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 UPF0312 protein VC0395_0473/VC395_A0785 (VC0395_0473, VC395_A0785) CSB-YP399624VEY
CSB-EP399624VEY
CSB-BP399624VEY
CSB-MP399624VEY
CSB-EP399624VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 L-ectoine synthase (ectC) CSB-YP399625VEY
CSB-EP399625VEY
CSB-BP399625VEY
CSB-MP399625VEY
CSB-EP399625VEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>